Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach

Completed · Phase 2

Conditions studied: Esophageal Cancer, Gastric Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of combining docetaxel and irinotecan in treating patients who have advanced cancer of the esophagus or stomach.

Key facts

Study ID
NCT00004235
Run by
Alliance for Clinical Trials in Oncology
People needed
47
Starts
2000-01-01
Expected to finish
2004-08-01
Last updated by the study team
2016-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.